Literature DB >> 10966503

Liver involvement in autosomal-dominant polycystic kidney disease: therapeutic dilemma.

Dominique Chauveau1, Fadi Fakhouri1, Jean-Pierre Grünfeld1.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10966503     DOI： 10.1681/ASN.V1191767

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  43 in total

1.  2-Hydroxyestradiol slows progression of experimental polycystic kidney disease.

Authors:  Sharon Anderson; Terry T Oyama; Jessie N Lindsley; William E Schutzer; Douglas R Beard; Vincent H Gattone; Radko Komers
Journal:  Am J Physiol Renal Physiol       Date:  2011-12-07

2.  Positron emission tomography in the diagnostic pathway for intracystic infection in adpkd and "cystic" kidneys. a case series.

Authors:  Giorgina B Piccoli; Vincenzo Arena; Valentina Consiglio; Maria Chiara Deagostini; Ettore Pelosi; Anastasios Douroukas; Daniele Penna; Giancarlo Cortese
Journal:  BMC Nephrol       Date:  2011-09-29       Impact factor: 2.388

3.  Intra-operative inferior vena cava syndrome in a patient with autosomal dominant polycystic kidney disease.

Authors:  S A Pierre; M T Jaeger; D R Siemens
Journal:  World J Urol       Date:  2006-01-25       Impact factor: 4.226

4.  A case of cardiac compression by hepatic cyst in a woman with polycystic kidney disease.

Authors:  Maurizio Li Vecchi; Silvio Buscemi; Emilio Nardi; Vitalba Azzolina; Rossana Provenzano
Journal:  Intern Emerg Med       Date:  2008-02-07       Impact factor: 3.397

Review 5.  Pathophysiology, epidemiology, classification and treatment options for polycystic liver diseases.

Authors:  Bassam Abu-Wasel; Caolan Walsh; Valerie Keough; Michele Molinari
Journal:  World J Gastroenterol       Date:  2013-09-21       Impact factor: 5.742

6.  Liver involvement in early autosomal-dominant polycystic kidney disease.

Authors:  Marie C Hogan; Kaleab Abebe; Vicente E Torres; Arlene B Chapman; Kyongtae T Bae; Cheng Tao; Hongliang Sun; Ronald D Perrone; Theodore I Steinman; William Braun; Franz T Winklhofer; Dana C Miskulin; Frederic Rahbari-Oskoui; Godela Brosnahan; Amirali Masoumi; Irina O Karpov; Susan Spillane; Michael Flessner; Charity G Moore; Robert W Schrier
Journal:  Clin Gastroenterol Hepatol       Date:  2014-08-09       Impact factor: 11.382

Review 7.  Surgical management of polycystic liver disease.

Authors:  Robert T Russell; C Wright Pinson
Journal:  World J Gastroenterol       Date:  2007-10-14       Impact factor: 5.742

Review 8.  Renal transplantation in autosomal dominant polycystic kidney disease.

Authors:  Nada Kanaan; Olivier Devuyst; Yves Pirson
Journal:  Nat Rev Nephrol       Date:  2014-06-17       Impact factor: 28.314

9.  Congenital abnormalities and hepatoblastoma: a report from the Children's Oncology Group (COG) and the Utah Population Database (UPDB).

Authors:  Rajkumar Venkatramani; Logan G Spector; Michael Georgieff; Gail Tomlinson; Mark Krailo; Marcio Malogolowkin; Wendy Kohlmann; Karen Curtin; Rachel K Fonstad; Joshua D Schiffman
Journal:  Am J Med Genet A       Date:  2014-06-16       Impact factor: 2.802

10.  Transcatheter arterial embolization therapy for a massive polycystic liver in autosomal dominant polycystic kidney disease patients.

Authors:  Hayne Cho Park; Chi Weon Kim; Han Ro; Ju-Young Moon; Kook-Hwan Oh; Yonsu Kim; Jung Sang Lee; Yong Hu Yin; Hwan Jun Jae; Jin Wook Chung; Curie Ahn; Young-Hwan Hwang
Journal:  J Korean Med Sci       Date:  2009-02-28       Impact factor: 2.153
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.